---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-004558"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:05:56.537705+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Moleculin posts new investor presentation on website

## Summary
- Filed under Item 7.01 as Regulation FD disclosure with Exhibit 99.1.
- Presentation is dated February 2026; actual content is an image exhibit not parsed.
- No specific financial, clinical, or operational data disclosed in the 8-K text.
- Investors should review the presentation on the company's website for details.

## SEC filing metadata
- accession: 0001437749-26-004558
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926004558/0001437749-26-004558-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926004558/mbrx20260217_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-004558
- JSON: https://secwatch.observer/filing/0001437749-26-004558.json
- Plain text: https://secwatch.observer/filing/0001437749-26-004558.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.